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In many kidney diseases, the original insult primarily
involves the glomerulus and may then pass onto the
tubulointerstitium. Several hypotheses link glomerular
disease to tubular injury; perhaps the foremost hypoth-
esis involves chronic tubular hypoxia. The reported ef-
fects of hypoxia and consecutive stabilization of hypoxia-
inducible factors (HIFs), however, are controver-
sial. Hypoxia induces interstitial fibrosis but also
has beneficial effects on renal disease progression
when HIF is activated pharmacologically. To ana-
lyze the impact of HIF on tubulointerstitial disease
development in primary glomerular disease, trans-
genic von Hippel Lindau (VHL)-knockout mice were
generated and null expression was induced before
the onset of autoimmune IgG-mediated anti–glo-
merular basement membrane glomerulonephritis
(GN). Tubular VHL knockout and, thus, local HIF-
stabilization increased renal production of vascular
endothelial growth factor, tumor growth factor–1,
and platelet-derived growth factor-B, resulting in
augmented formation of capillaries and interstitial
matrix, and conversion of fibroblasts to myofibro-
blasts. Within the glomerular disease, VHL knock-
out reduced the glomerular damage and attenuated
tubulointerstitial injury. Likewise, proteinuria,
plasma urea concentration, and tubulointerstitial
matrix were decreased in VHL knockout with GN.
These findings shown that tubular HIF- stabiliza-
tion in glomerular disease is beneficial for disease
outcome. In comparison with VHL knockout alone,
GN is a much stronger activator of fibrosis such that
stimuli other than hypoxia may be considered im-Many forms of acute glomerulonephritis (GN) tend to
progress to chronic GN, which is characterized by irre-
versible, progressive glomerular and tubulointerstitial fi-
brosis. The insult involves primarily the glomerulus and
then may be transferred to the tubulointerstitium, but the
relationship between glomerular damage and tubular in-
jury remains incompletely understood.1–3 There are sev-
eral hypotheses linking primary glomerular disease to
tubular injury; perhaps the foremost involves the occur-
rence of tubular hypoxia.4,5
Renal hypoxia may result from a combination of struc-
tural and functional changes. Structural alterations in-
clude capillary rarefaction; compromised peritubular
blood flow resulting from glomerular injury, which may
involve the efferent arterioles and affect the blood supply
for the tubule; and limited oxygen diffusion as a conse-
quence of extracellular matrix expansion. Functional
changes comprise vasoconstriction from altered levels of
vasoactive factors and signaling molecules, increased
oxygen demand from hyperfiltration and tubular hyper-
trophy, and renal anemia.4,6,7
Hypoxic conditions lead to stabilization of hypoxia-
inducible factors (HIF) belonging to the Per-ARNT-Sim
family of basic helix-loop-helix transcription factors and
consisting of an oxygen-sensitive -subunit and a con-
stitutively expressed -subunit.8 Under conditions of nor-
mal oxygen tension HIF is hydroxylated and rapidly de-
graded by proteasomal inactivation. von Hippel-Lindau
(VHL) is a component of the E3 ubiquitin ligase that
targets proteins for degradation in the proteasome. Loss
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of VHL leads to stabilization of HIF- subunits. On in-
creased stability of HIF- subunits, they translocate into
the nucleus to form a heterodimer with the -subunit. The
heterodimer then binds to the hypoxia-response ele-
were primed immunologically by subcutaneous injec-
tion of rabbit IgG in complete Freund’s adjuvant. GN
was induced 6 days later by the intravenous injection
of a rabbit anti-mouse GBM serum16 (n  20), whereas
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genes participating in cell adaptation to hypoxia. There
are more than 100 genes whose expression is medi-
ated by HIF, and that control cell metabolism, survival,
angiogenesis, vascular tone, and tissue oxygenation.6
The effects of hypoxia and HIF- induction on the pro-
gression of a renal disease, however, are discussed
controversially. Renal HIF-1 expression correlates
with the degree of tissue injury and fibrosis,9 suggest-
ing a relevance to the development and progression of
kidney diseases. Conversely, activation of HIF has
been shown to ameliorate disease development in anti-
Thy1 GN,10 remnant kidney model,11 and in a model of
diabetic nephropathy.12
To analyze the impact of tubular HIF- induction in the
setting of a transfer from a primary glomerular disease
onto the tubulointerstitium, a preventive strategy was
chosen. Therefore, a tetracycline-inducible VHL-knock-
out mouse model was generated and induced before the
onset of a rapid progressive GN. VHL knockout resulted
in augmented interstitial capillary proliferation and mar-
ginal matrix production. However, anti–glomerular base-
ment membrane (GBM) GN was significantly less devel-
oped in VHL knockout mediated through diminished
glomerular disease development. In this context, the ben-
eficial effects of tubular HIF- stabilization clearly over-
balanced the harmful increase in interstitial matrix, lead-
ing to attenuation in disease progression.
Materials and Methods
Transgenic Animals
A conditional transgenic system was used to disrupt VHL
expression within the renal tubular system of adult mice.
Three transgenic mouse lines were cross-bred: i) Pax8–
reverse tetracycline-dependent transactivator mice,
which express the reverse tetracycline-dependent trans-
activator under control of the Pax8 promoter (expressed
along the tubular system and periportal hepatocytes with
an efficiency of 65%),13 ii) LC-1 mice, which express
Cre recombinase under the control of the bidirectional
Ptet promoter,
14 and iii) VHLflox/flox mice for targeted dis-
ruption of VHL.15 All mice were genotyped by PCR anal-
ysis of tail DNA for Pax8–reverse tetracycline-dependent
transactivator, LC-1, and VHLflox/flox.
Experimental Design
A total of 32 3-month-old male mice from several litters
were used and divided into four groups. For the induc-
tion of the VHL knockout, mice (n  16) received 0.2
mg/mL doxycycline/5% glucose in the drinking water
for 2 days. The control mice (n  16) received only 5%
glucose in the drinking water. Initiation of VHL knock-
out was performed 3 days before the anti-GBM admin-
istration. For the induction of the anti-GBM GN all micethe control mice (n  12) received an injection of
vehicle (0.9% NaCl). All mice were sacrificed after 18
days of anti-GBM GN treatment.
Group specification was as follows: group 1 (DOX;
n  6) received vehicle injection; group 2 (DOX; n  6)
received 0.2 mg/mL doxycycline and vehicle injection;
group 3 (DOX/GN; n  10) received injection of rabbit
anti-GBM serum; and group 4 (DOX/GN; n  10) re-
ceived 0.2 mg/mL doxycycline and injection of anti-GBM
serum. The experimental design of this study was ap-
proved by the local authorities according to the German
and Swiss laws for protection of animals (registered un-
der G 0178/03 and Fr 51/10).
Before the experiment and then once a week after-
ward, 200 L of blood was collected by puncture of the
submandibular vein from each animal under isoflurane
anesthesia. Hemoglobin concentration was determined
by ABL800 FLEX (Radiometer, Willich, Germany). Plasma
urea nitrogen was quantified enzymatically using routine
automated methods (Modular Analytics; Roche Diagnos-
tics, Mannheim, Germany). Plasma vascular endothelial
growth factor (VEGF) levels were determined by a commer-
cial enzyme-linked immunosorbent assay (Raybiotech,
Heidelberg, Germany). For urinary protein analysis, mice
were placed individually in metabolic cages for 24 hours
and urine protein concentration was measured with a stan-
dardized autoanalyzer (Hitachi 747; Roche Diagnostics).
Detection of Circulating Anti-Rabbit IgG
For the detection of circulating anti-rabbit IgG, microtiter
plates were coated with 100 g/mL rabbit IgG (Jackson
Laboratories, West Grove, PA) followed by blocking with
5% skim milk and incubation with mouse serum obtained
from each animal at the end of the experiment. After the
incubation with horseradish-peroxidase–conjugated goat
anti-mouse IgG (Abcam, Cambridge, UK) the signal was
generated using 3,3=,5,5=-tetramethylbenzidine (Sigma Al-
drich, München, Germany) and measured at 450 nm.
Perfusion, Fixation, and Tissue Processing
Mice were anesthetized by an intraperitoneal injection of
sodium pentobarbital (0.06 mg/g body weight). After lap-
arotomy, one kidney was clamped, removed, and shock-
frozen for biochemical analysis and the other kidney then
was perfused in vivo via the abdominal aorta using 3%
paraformaldehyde. For cryostat sectioning, tissues were
shock-frozen and stored at 80°C. Alternatively, tissues
were postfixed in 3% paraformaldehyde, dehydrated,
and standard paraffin-embedded. For ultrastructural
analysis, kidney specimens were postfixed in 1.5% para-
formaldehyde/PBS containing 1.5% glutaraldehyde, and
0.05% picric acid, rinsed, and stored in PBS until embed-
ding in Epon (Serva, Heidelberg, Germany). Ultrathin
sections were viewed in a Zeiss EM 906 electron micro-
scope (Zeiss, Oberkochen, Germany).
RNA Isolation, Reverse Transcription, and Real-
Time PCR
cam), and rabbit anti–HO-1 (Acris). For all antibodies,
negative controls were used in which the primary anti-
body was omitted. For double-labeling, primary antibod-
ies were administered consecutively. Light microscopy
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the RNeasy Mini kit (Qiagen, Hilden, Germany). Genomic
DNA was digested by DNase I (Invitrogen, Carlsbad, CA),
and cDNA was synthesized by reverse transcription of 5 g
of total RNA (SuperScript First-Strand Synthesis System;
Invitrogen). TaqMan Gene Expression Assays were used,
and the product IDs were as follows: erythropoietin,
Mm01202755_m1; VEGF-A, Mm00437306_m1; tumor
growth factor–1 (TGF-1), Mm03024053_m1; and platelet-
derived growth factor-B (PDGF-B), Mm01298578_m1. The
experiments were performed according to the manual pro-
vided by Applied Biosystems (Foster City, CA). Amplifica-
tions were performed using the real-time PCR TaqMan Fast
7500 (Applied Biosystems). Threshold cycle values were
set in the linear phase of exponential amplification. The
difference ( threshold cycle) between values obtained for
erythropoietin, VEGF, TGF-1, PDGF-B, and the house-
keeping genes 28S ribosomal RNA Mm03682676_s1 and
TATA-box binding protein Mm00446973_m1 were calcu-
lated and the mRNA abundance of all four groups is pre-
sented in percentages.
In Situ Hybridization
The mRNA expression of TGF-1 and osteopontin was
investigated by in situ hybridization using digoxigenin-
labeled riboprobes (Roche). Sense and antisense probes
were generated by in vitro transcription of a 700-bp
TGF-1 cDNA and a 1100-bp osteopontin cDNA tem-
plate. In situ hybridization was performed on 5-m–thick
paraffin sections according to an established protocol.17
Signal was generated with 4-nitroblue tetrazolium chlo-
ride. For control, sense probes were applied in parallel
with antisense probes.
Immunohistochemistry
Immunohistochemistry for VHL, HIF-1, HIF-2, and
heme oxygenase-1 (HO-1) was performed on 4-m–thick
paraffin sections using the Catalyzed Signal Amplification
System (Dako, Baar, Switzerland). VEGF immunostaining
was performed with the Vectastain ABC kit (Vector, Bur-
lingame, CA). Immunohistochemistry using fluorescence-
coupled secondary antibodies was used for all other
immunodetections. The following antibodies were used:
polyclonal rabbit anti-VHL (Labforce, Nunningen, Swit-
zerland), polyclonal rabbit anti-HIF1 (Cayman Chemi-
cals, Ann Arbor, MI), polyclonal rabbit anti-HIF2 (PM9
kindly provided by Patrick Maxwell), polyclonal goat anti-
VEGF antibody (R&D Systems, Minneapolis, MN), poly-
clonal rabbit anti-rat type I collagen antibody (Biotrend,
Köln, Germany), polyclonal rabbit anti–Wilms tumor-1 an-
tibody (Santa Cruz Biotechnology, Heidelberg, Ger-
many), monoclonal rat anti–Ki-67 antibody (Dako), rabbit
anti-5=ectonucleotidase (kind gift from Johannes Loffing),
polyclonal rabbit anticaveolin (Santa Cruz Biotechnol-
ogy), polyclonal rabbit anti–TGF-1 (Acris, Herford, Ger-
many), rabbit anti–-smooth muscle actin (-SMA; Ab-specimens were evaluated using a Leica DMRB fluores-
cence microscope (Leica Microsystems, Heerbrugg,
Switzerland) equipped with a digitized camera system
and MetaView software (Visitron Systems, München,
Germany). Immunofluorescence microscopy specimens
were analyzed using a confocal scanning microscope
(TCS SP-2; Leica Microsystems).
Western Blotting
Total kidney homogenate was produced using sucrose
buffer containing 250 mmol/L sucrose, 10 mmol/L trieth-
anolamine, and protease inhibitor cocktail (Complete,
Roche Diagnostics) and centrifuged to remove nuclei
and cellular debris. Total protein concentration was mea-
sured using the Pierce BCA Protein Assay reagent kit
(Rockford, IL) and controlled by Coomassie staining. Fifty
micrograms of protein was loaded onto 10% to 12%
gradient polyacrylamide gels. After SDS-PAGE and elec-
trophoretic transfer of proteins to nitrocellulose mem-
branes, equal protein loading and blotting was verified by
membrane staining using Ponceau red. Membranes were
probed overnight with antibodies directed against VHL,
VEGF, TGF-1, -SMA, type 1 collagen, and HO-1, followed
by exposure to horseradish-peroxidase–conjugated sec-
ondary antibodies (Dako). Immunoreactive bands were de-
tected on the basis of chemiluminescence, using an en-
hanced chemiluminescence kit (Amersham Biosciences,
Buckinghamshire, UK) before exposure to X-ray films (Hy-
perfilm, Amersham Biosciences). For densitometric evalua-
tion of the resulting bands, films were scanned and ana-
lyzed using BIO-PROFIL Bio-1D image software (Vilber
Lourmat, Marne-la-Vallée, France).
Morphometry
Damage Scoring
Glomerular and tubulointerstitial damage was deter-
mined as described,16,18,19 and assessed on PAS-
stained paraffin sections. A semiquantitative glomeru-
losclerosis score was established by grading the
severity of sclerosis for each glomerulus. Grading was
set from 0 to 4 with 0 representing no lesion, 1 repre-
senting sclerosis of less than 25% of the glomerulus,
and 2, 3, and 4 representing sclerosis of 25% to 50%,
50% to 75%, and more than 75% of the glomerulus,
respectively. A whole kidney average sclerosis index
was obtained by averaging scores of all glomeruli on
one section. On average, 100 to 150 glomeruli were
assessed per mouse. The glomerular damage com-
prised segmental or global collapse of capillaries, with
or without associated hyaline deposition, adhesion of
the capillary tuft to Bowman’s capsule, detachment of
podocytes from the GBM, and thickening of mesangial
matrix. To assess tubulointerstitial changes a semi-
quantitative score was established to evaluate the de-
gree and extent of tubulointerstitial damage of each
field and was graded from 0 to 4 as follows: 0 repre-
sents no lesion, 1 represents tubulointerstitial damage
of less than 25% per field, and 2, 3, and 4 represent
phy, detachment of cells from the basement mem-
brane, thickening of the tubular basement membrane,
number of interstitial cells, and interstitial fibrosis.
2180 Theilig et al
AJP November 2011, Vol. 179, No. 5tubulointerstitial damage of 25% to 50%, 50% to 75%,
and more than 75% of the tubulointerstitium, respec-
tively. Approximately 30 cortical and medullary visual
fields (20) per kidney were evaluated. Tubulointersti-
tial injury was defined by features such as tubular
collapse, cast formation with tubular dilatation or atro-
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using the following formula: VT  (/k)(tuft areas)3/2,
where   1.38 (shape coefficient for spheric particles)
and k  1.1 (size distribution coefficient for spheres).19
Glomerular Capillary Density
Semithin plastic sections were stained with Richard-
son’s solution. The area of perfused glomerular capillar-
ies was estimated stereologically on 30 glomeruli per
animal. The density of perfused capillaries was calcu-
lated by relating the area of perfused capillaries to the
measured tuft area.
Tubulointerstitial Capillary Density
Semithin sections were used to estimate the fraction of
the tubular circumference that is in close contact to cap-
illaries. Approximately 50 cortical tubules per animal
were evaluated stereologically and capillary-epithelial
contact areas were calculated for all four grades of tubu-
lar degeneration as described by Le Hir and Besse-
Eschmann.20
Cellular Proliferation
Cell proliferation was assessed with the Ki-67 antibody
technique using paraffin sections. The number of Ki-67–
positive endothelial nuclei (as determined by double-
labeling with caveolin) was estimated. Results from nu-
meric evaluation were expressed as the number of
labeled glomerular cells per glomeruli or tubulointerstitial
cells per visual field (40). The number of Ki-67–positive
epithelial cells were counted and expressed as the num-
ber of Ki-67–positive epithelial cells per visual field (40).
Presentation of Data and Statistical Analysis
Quantitative data are presented as means  SD. For
statistical comparison, the Mann-Whitney U-test was
used. P  0.05 were considered statistically significant.
Results
Induction of VHL Knockout and GN
Immunohistochemistry of VHL revealed an expression in
the proximal tubule with predominance in the convoluted
Table 1. Abundance of EPO, VEGF, TGF-1, and PDGF-B mRNA
DOX D
EPO 1.00  0.47 0.03 
VEGF 1.00  0.09 2.17 
TGF-1 1.00  0.34 1.52 
PDGF-B 1.00  0.67 2.75 
Control levels DOX are set as 1  100%. Means  SD; n  7.
*P  0.05 DOX versus DOX.
†P  0.05 control versus GN.Western blot analysis of VHL on renal tissue confirmed
the kidney targeted deletion of about 65% (see Supple-
mental Figure S1 at http://ajp.amjpathol.org). Administra-
tion of doxycycline resulted in the well-established reduc-
tion of target gene degradation as shown by the strong
nuclear expression of HIF-1 and HIF-2 in the DOX
groups (Figure 1, B and C). As expected, no signal was
observed in podocytes.13 Occasionally, GN induced
epithelial HIF-1 expression in the distal tubule and
HIF-2 in single cells of the proximal tubule. In some mice
strains, the transition of the parietal epithelial cells toward
the proximal tubule occurs in the Bowman’s capsule,
therefore positive HIF-1 and HIF-2 signals within the
early proximal tubule can be observed in the glomerulus.
Morphologic analysis of glomeruli and the tubulointersti-
tium did not reveal signs of damage on induction of VHL
knockout (Figure 1, D–F). Both DOX/GN and DOX/GN
groups developed crescentic GN with tubulointerstitial dis-
ease after injection of the anti-GBM serum. The histopatho-
logic changes were qualitatively identical in both groups but
were quantitatively significantly less pronounced in
DOX/GN than in DOX/GN. Glomeruli of the DOX/GN
displayed less hyaline deposits, sclerotic capillaries, tuft
adhesions, and cellular crescent formation. Similarly, tubu-
lointerstitial damage was less pronounced in DOX/GN
compared withDOX/GN, showing fewer tubular dilations,
cast formations, tubular atrophy, and degeneration.
Next, we correlated the damage scores of glomeruli
and tubulointerstitium in DOX/GN and DOX/GN. A
strict linear correlation (DOX/GN, r 0.897;DOX/GN,
r  0.946; both P  0.05) with similar correlation coeffi-
cients was found in the two groups that were compared.
Administration of doxycycline increased the blood he-
moglobin concentration (DOX: 14.7  0.2 g/dL versus
DOX: 18.5  1.3 g/dL; P  0.05) and hematocrit
(DOX: 40.8%  1.7% versus DOX: 47.3%  3.2%;
P  0.05) in DOX groups compared with DOX
groups. Mice were bled once a week to avoid secondary
effects of polycythemia as shown by the time-course of
hemoglobin concentration (see Supplemental Table S1 at
http://ajp.amjpathol.org). However, renal erythropoietin
mRNA concentration was reduced significantly in both
DOX and DOX/GN groups (Table 1). Therefore, we
assume that Pax8-driven hepatic erythropoietin produc-
tion could be responsible for the increased blood hemo-
globin concentration and hematocrit. Furthermore, the
DOX/GN DOX/GN
0.54  0.33 0.01  0.01*
1.44  0.59 2.38  0.46*
2.18  0.65† 1.89  0.25
0.95  0.25 2.35  0.86*0.62*
0.51
0.98*
Table 2. Clinical Parameters
DOX DOX DOX/GN DOX/GN
P-urea (mg/dL) 27.7  4.8 21.8  5.8 43.7  10.9* 34.8  4.1*†
2182 Theilig et al
AJP November 2011, Vol. 179, No. 5results foster the idea of an exclusively interstitial source
of renal erythropoietin mRNA production.
Induction of GN led to strongly increased plasma urea
concentration and proteinuria in DOX/GN and DOX/
GN. However, in agreement with the reduced glomerular
and tubulointerstitial damage of DOX/GN compared
with DOX/GN, plasma urea concentration and urinary
protein excretion were less pronounced (Table 2). In ad-
dition, the time-course of plasma urea concentration
showed a lower augmentation in DOX/GN compared
with DOX/GN (see Supplemental Table S1 at http://
ajp.amjpathol.org).
The difference in disease progression may not be re-
lated to the humoral immune response to the injected
rabbit anti-GBM serum because comparable amounts of
mouse anti-rabbit IgG were produced in both GN groups
(arbitrary units at OD 450: DOX/GBM 0.48  0.09 and
DOX/GBM 0.49  0.12).
Analysis of Capillary Density and Endothelial Cell
Proliferation
Morphologic analysis of both DOX and DOX/GN re-
vealed an increase in capillary density. VEGF and PDGF-B
U-protein (mg/24 hours) 0.6  0.5
Values were determined on the last day of the experiment and are m
*P  0.05 control versus GN.
†P  0.05 DOX versus DOX.
P-urea, plasma ureal; U-protein, urinary protein.
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Then, renal VEGF protein abundance was determined
by Western blot analysis and immunohistochemistry. In
comparison with DOX, immunohistochemical analysis
of VEGF revealed in DOX and DOX/GN a strong aug-
mented expression along the tubule, whereas the podo-
cyte VEGF expression was decreased (Figure 2A).
DOX/GN showed a slight increase in tubular and glo-
merular VEGF expression levels in animals with low dis-
ease score and showed the tendency to be reduced in
mice with higher glomerular and tubulointerstitial dam-
age. Immunohistochemical data were confirmed by
Western blot analysis (Figure 2B). Similarly, in compari-
son with DOX, serum VEGF levels started to augment
continuously by 1 week after administration of doxycy-
cline and/or anti-GBM GN induction. The highest levels of
circulating VEGF were observed in both DOX groups
(Figure 2C; see also Supplemental Table S1 at http://
ajp.amjpathol.org).
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AJP November 2011, Vol. 179, No. 5Next, glomerular and tubulointerstitial endothelial cell
proliferation were assessed. In comparison with DOX,
in which no glomerular endothelial cell proliferation was
found, a strongly increased number of Ki-67–positive en-
dothelial cells per glomeruli was detected in all three
groups with the highest amount observed in DOX and
DOX/GN (Figure 3, A and B). Similar results were ob-
tained for the tubulointerstitial endothelial cell prolifera-
tion. In DOX only minor tubulointerstitial endothelial cell
proliferation was found. A strong increase in the number
of Ki-67–positive endothelial cells per visual field were
observed in all three groups, again with highest expres-
sion levels in DOX and DOX/GN (Figure 3, C and D).
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with DOX groups. Reduced glomerular and tubulointerstitial damage of 
glomerular capillary length.H: Stereologic evaluation of tubule-capillary cont
contact area of DOX/GN compared with DOX/GN according to the grad
versus GN. Scale bars: 20 m.We then assessed the glomerular capillary density and
the tubular-capillary contact. Compared with DOX,
glomeruli ofDOX showed a significant augmented cap-
illary density (Figure 3, E and G). Induction of GN strongly
reduced the glomerular capillary density but remained
higher in DOX/GN compared with DOX/GN. Similar to
the glomeruli, the tubular-capillary contact area was
higher in DOX than in DOX (Figure 3, F and H). To
analyze whether the grade of the tubular degeneration
affects the proportion of the tubular-capillary contact
area, stereologic analysis was performed on all four
grades of degeneration according to the established de-
scription.20 With increased tubular degeneration the frac-
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AJP November 2011, Vol. 179, No. 5tion of the tubular-capillary contact area continuously de-
creased in both DOX/GN and DOX/GN, but remained
constantly higher in DOX/GN (Figure 3I).
Analysis of Interstitial Alterations
VHL knockout was proposed to induce interstitial matrix
production. Therefore, the expression levels of TGF-1,
-SMA, and type 1 collagen were determined. Compared
with DOX, TGF-1 mRNA was increased significantly in
all three groups with the highest mRNA expression level
in DOX and DOX/GN (Table 1). TGF-1 protein ex-
pression levels were increased significantly in all three
groups compared with DOX. However, the highest
abundance was found in both GN groups (Figure 4A). In
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Figure 4. Induction of interstitial matrix production on administration of dox
(B), and type 1 collagen (C) expression. D–F: Immunohistochemistry of TGF
the interstitial expression of TGF-1, -SMA, and type 1 collagen. Induction
DOX/GN and DOX/GN. P  0.05 for DOX versus DOX; †P  0.05DOX kidneys, immunohistochemical analysis showed
only faint TGF-1 expression in medullary collecting
ducts; in DOX kidneys additional interstitial expression
was found (Figure 4D). Induction of GN strongly aug-
mented TGF-1 expression in tubular and interstitial cells.
Immunohistochemical staining was confirmed by in situ
hybridization of TGF-1 mRNA showing the same expres-
sion pattern and changes in intensity levels (not shown).
Similar variations in expression levels were obtained for
-SMA and type 1 collagen (Figure 4, B and C). Com-
pared with DOX, kidneys of DOX showed increased
interstitial -SMA and type 1 collagen expression (Figure
4, F and G). Again, the strongest augmentation of both
proteins was found after induction of GN in DOX/GN
and DOX/GN.
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AJP November 2011, Vol. 179, No. 5The observed strong increase in -SMA–positive in-
terstitial cells suggests an increased formation of myo-
fibroblasts. To analyze whether the latter could be ow-
ing to increased fibroblast/myofibroblast proliferation
Ki-67 and 5=ectonucleotidase-positive cells were
counted. Compared with the DOX condition, a signif-
icant increase of proliferating fibroblast/myofibroblasts
were observed in DOX, DOX/GN, and DOX/GN
(Figure 5, A and B).
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Figure 5. Interstitial cell proliferation. A: Numeric evaluation of proliferating
interstitial cells. B: Representative double labeling of Ki-67 (red) and 5=ecto-
nucleotidase (green) of DOX. Arrowheads mark proliferating interstitial
cells. Scale bar  20 m. P  0.05 for DOX versus DOX; †P  0.05 for
control versus GN.mined. DOX kidneys showed osteopontin expression
only in medullary collecting ducts (Figure 6A), in DOX
kidneys an additional cortical distal tubular signal was
found. However, strong osteopontin expression was
observed along the nephron in DOX/GN and less in
DOX/GN. Then, the epithelial proliferation index was
determined by counting Ki-67–positive epithelial cells
per visual field. Compared with DOX, the number of
Ki-67–positive epithelial cells strongly increased in
DOX and DOX/GN and the highest proliferation rate
was assessed in DOX/GN (Figure 6B; respective val-
ues are as follows: DOX 1.0  0.2 g/dL; DOX 3.5 
1.3 g/dL, P  0.05; DOX/GN 3.9  1.9, P  0.05;
DOX/GN 12.2  1.7, P  0.05).
HO-1 expression could not be determined in DOX
kidneys. Administration of doxycycline and GN, however,
induced its expression in all tubular epithelial cells, with
the highest expression levels found in DOX and
DOX/GN (Figure 7, A and B).
Discussion
VHL knockout was associated with increased renal tubu-
lar stability of the transcription factors HIF-1 and HIF-2.
−DOX/GN +DOX/GN
Figure 6. Expression of tubular damage marker. A: In situ
hybridization of osteopontin mRNA expression. In DOX
kidneys no cortical osteopontin mRNA is observed. Admin-
istration of doxycycline induced a faint expression in the
distal tubule. On GN induction, strong proximal and distal
tubular osteopontin expression is found in DOX/GN and
DOX/GN with less abundance inDOX/GN. B: Represen-
tative immunohistochemical images of Ki-67–positive epi-
thelial cells. Compared to DOX, administration of doxycy-
clin and induction of GN increased the number in
proliferating epithelial cells with highest amount in DOX/
GN. Scale bars: 20 m.
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AJP November 2011, Vol. 179, No. 5Renal epithelial expression of HIF-1 is well documented,
whereas HIF-2 was found mainly in renal interstitial fi-
broblasts and endothelial cells.21 However, greater nu-
clear HIF-1 and HIF-2 stabilization was observed in the
pathogenesis of VHL disease with constitutive epithelial
expression of both HIF-1 and HIF-2,22 confirming the
potential of epithelial cells to generate HIF-2.
VEGF, a target common to both HIF-1 and HIF-2,23
was strongly produced in renal tubules of DOX and
DOX/GN, leading to a concomitant fourfold increase in
plasma VEGF concentration. As shown in a recent study
by Hakroush et al,19 renal VEGF production is indeed
capable in increasing systemic VEGF serum levels, initi-
ating a feedback-mediated decrease in VEGF production
by podocytes, which is similar to what we encountered in
DOX and DOX/GN. Augmented VEGF levels were
reported to induce glomerular changes19,24,25; however,
glomerular morphology strongly differed between trans-
genic mice models overexpressing VEGF, which most
likely is owing to the varying concentrations of VEGF.
Serum VEGF levels increase as a consequence of renal
epithelial VHL knockout, leading to glomerular endothe-
lial proliferation associated with capillary growth.26,27
Surprisingly, GN induced continuously higher serum
VEGF levels over time, albeit with unchanged or dimin-
ished expression in the kidney at the end of the animal
experiment. A possible explanation could be the time-
course of renal VEGF expression/secretion, which was
shown to be increased at the beginning of acute GN and
decreased with ongoing disease progression.28,29
In VHL knockout mice, the magnitude of GN was re-
duced and glomerular morphologic alterations were
ameliorated, leading to significantly reduced proteinuria
and plasma urea concentration. VEGF-induced reduction
in glomerular hydrostatic pressure by arteriolar vasodila-
tion30 and/or increased glomerular surface area available
for filtration affecting the filtration coefficient may be re-
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*700sponsible. Brenner and colleagues31 were able to show
that chronic moderate anemia, known to induce epithelial
HIF-1 expression,32 prevented the development of glo-
merular hypertension and retarded the progression of
structural injury in the deoxycorticosterone acetate-salt
model of progressive renal disease. A protective effect of
VEGF administration also was observed in the remnant
kidney model33 with increased glomerular capillary den-
sity associated with preservation of the glomerular filtra-
tion rate. In addition, increased circulating VEGF also
may account for the disease amelioration by mediating
endothelial cell maintenance and survival.34
Progressive interstitial fibrosis is associated with the
loss of peritubular capillaries,35 which would be ex-
pected to result in chronic ischemia and hypoxia, which,
in turn, was assumed to induce endothelial cell apoptosis
and therefore to further stimulate the scarring process.7
In our model, the high VEGF levels induced a strong
proliferation of peritubular endothelial cells, showing the
capacity to respond to hypoxia similarly as endothelial
cells elsewhere. Increased formation of capillaries in both
DOX groups led to an augmented fraction of tubular
epithelial cells being surrounded by capillaries. The frac-
tion of the tubule-capillary contact area was always sig-
nificantly higher in DOX/GN compared with DOX/GN.
However, both tended to analogously decrease with the
grade of tubule degeneration despite maximal HIF- sta-
bilization, VEGF generation, and angiogenesis in DOX/
GN. Moreover, the correlation of the glomerular with the
tubulointerstitial damage of DOX/GN and DOX/GN
resulted in very similar correlation coefficients. This
shows that VHL knockout with presumably improved ox-
ygen supply does not prevent or ameliorate tubular de-
generation in this mouse model of GN. We share the
concept that the normal tubular epithelium secretes an-
giogenetic factors for proper oxygen supply, but when
Figure 7. Expression of HO-1. Immunohistochemistry (A)
and Western blot analysis (B) with densitometric evaluation
of HO-1. Compared with DOX, in which no signal was
detectable, administration of doxycycline and induction of
GN strongly increased HO-1 expression level with the high-
est abundance in DOX/GN. Scale bars: 20 m. P  0.05
for DOX versus DOX; †P  0.05 for control versus GN.
degenerating the secretion is diminished and capillaries
disappear secondarily.36
Profibrotic properties of HIF have been described,9
leading to the hypothesis that hypoxia is not only a result
showing the same correlation coefficient between glomer-
ular and tubulointerstitial damage scores.
In conclusion, we can confirm that stabilization of HIFs
through VHL knockout has renoprotective effects by
VHL Deficiency in Anti-GBM-Nephritis 2187
AJP November 2011, Vol. 179, No. 5of but also a cause for fibrosis, leading to a vicious circle.
VEGF, as a HIF-target gene, was shown to induce TGF-1
production and secretion in vitro.37 Recently, transgenic
mice overexpressing VEGF in renal epithelia19 stimulated
endothelial cells to produce TGF-1 and PDGF-B, both
cytokines are known to induce the conversion of fibro-
blasts into myofibroblasts.38,39 In our study, VHL knock-
out induced mild endothelial TGF-1 and PDGF-B pro-
duction and enhanced expression of myofibroblasts, as
revealed by -SMA–positive interstitial staining associ-
ated with increased type 1 collagen synthesis. These
results are in agreement with the reduced fibrotic effect in
HIF-1 knockout mice after ureteral ligation.9 However,
in DOX, renal tubules remained unaffected by the in-
creased interstitial matrix production and renal function
persisted at control level during the experiment. Induc-
tion of GN induced a strong increase in TGF-1 and
interstitial matrix production assuming that other stronger
stimuli than hypoxia may account for the massive fibro-
blast conversion and collagen production in GN.
For analysis of tubular affections the expression of the
adhesion molecule osteopontin and the epithelial prolif-
eration index were determined. Both were associated
with tubular damage and fibrosis. The strongest osteo-
pontin expression levels were found after induction of
GN, with the highest expression in DOX/GN and to a
lesser extent in DOX/GN. This expression pattern
showed similar characteristics to the morphologic altera-
tions in both disease groups. Osteopontin induced
TGF-1 production and fibrosis,
40 which is in line with the
reduced tubulointerstitial damage score, TGF-1, -SMA,
and type 1 collagen expression in DOX/GN compared
with DOX/GN. An increased number of proliferating
tubular cells were observed on VHL knockout and anti-
GBM GN, most likely through different mechanisms, as
shown by the additive effect obtained in DOX/GN. Re-
cent publications have indicated that limiting cell prolif-
eration could reduce fibrosis development.41 Further-
more, cell proliferation was shown to be associated with
a less-differentiated state, and therefore proliferating
cells might be more prone to deposit matrix proteins. On
the contrary, HO-1, an HIF target gene and redox-sensi-
tive protein, provides protection from disease. HO-1 is
the rate-limiting enzyme involved in the degradation of
heme and is known to have cytoprotective effects6 by the
anti-inflammatory, anti-apoptotic, and antiproliferative ac-
tions of its end by-products.42 The role of HO-1 in renal
fibrosis was clarified by Kie et al,43 showing that HO-1
knockout mice had significantly greater tubular TGF-1 ex-
pression, inflammation, and fibrosis after unilateral ureteral
obstruction. In our experimental outline HO-1 was ex-
pressed most abundantly in all tubular epithelial cells of
both DOX and DOX/GN groups compared with a mod-
erate expression pattern in DOX/GN. These results show
that induction of HIF- may have damaging and protective
impacts on the tubulointerstitium; however, net effects seem
to be counterbalanced, as established in our experimentameliorating glomerular disease progression in the anti-
GBM GN mouse model, most probably mediated by in-
creased circulating VEGF and associated angiogenesis.
However, related to the tubulointerstitium, VHL knockout–
induced effects were balanced within the anti-GBM GN;
therefore, neither beneficial nor destructive properties
were encountered. Hypoxia with concomitant HIF stabi-
lization thus may be only a mild stimulus for the renal
disease progression, and other factors need to be iden-
tified for the strong progression observed in anti-GBM
GN. In addition, increased tubulointerstitial capillary for-
mation did not halt disease progression. We hypothesize
that as long as the tubule functions properly, angioge-
netic factors are secreted, establishing the desired oxy-
gen supply. Rarefaction of interstitial capillaries may be
secondary to tubule degeneration.
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